Highest-materiality recent filing
Herbalife Q1 net sales $1.3B (+7.8% YoY); raises FY2026 constant-currency guidance midpoints
Q1 net sales $1.3B (+7.8% YoY); adjusted EBITDA $175.7M above guidance; diluted EPS $0.57, adjusted $0.64.
Herbalife completes $1.45B refinancing, issues $800M 7.75% notes due 2033, redeems 12.25% notes
Issued $800M aggregate principal of 7.750% Senior Secured Notes due 2033 (the '2033 Secured Notes').
$800M aggregate principal at 7.750% fixed, due 2033; priced at 100% of par.
Preliminary Q1 net sales growth 7.5-8.0% YoY (5.0-5.5% constant currency), beating high end of guidance; Adj. EBITDA at or above guidance.
Herbalife Q4 net sales +6.3% to $1.3B, adj EBITDA $156.1M; Ronaldo invests $7.5M in Pro2col
Q4 net sales $1.3B, +6.3% YoY; constant currency +5.5%; both exceed guidance.
Herbalife Q3 net sales $1.3B (+2.7% YoY), adj. EBITDA $163M beats guidance; tightens FY25 ranges
Net sales $1.3B, above guidance midpoint; up 2.7% YoY (3.2% constant currency).
Herbalife Q2 net sales $1.3B near guidance mid; adjusted EBITDA $173.6M beats; raises 2025 outlook
Net sales of $1.3B down 1.7% YoY (flat constant currency); net income $49.3M, diluted EPS $0.48.
Herbalife Q1 net sales $1.2B (down 3.4% YoY), adjusted EBITDA $164.9M beats guidance
Net sales $1.2B at midpoint of guidance; down 3.4% YoY but up 1.4% on constant-currency basis.
Herbalife Q4 Adj EBITDA $150M beats guidance; Stephan Gratziani appointed CEO
Q4 net sales $1.2B, down 0.6% YoY but up 2.7% constant currency; at high end of guidance.
Base salary $1.28M; annual bonus target $1.92M (max 300% of salary).
Net sales $1.2B, down 3.2% YoY (flat constant currency); net income $47.4M, diluted EPS $0.46.
Herbalife Q2 adj. EBITDA $180M, beats guidance; FY 2024 EBITDA raised
Net sales $1.3B, down 2.5% YoY but constant currency up 0.2%, driven by Latin America, EMEA, Asia Pacific.
Herbalife Q1 net sales $1.3B (+1% YoY); raises full-year adjusted EBITDA guidance
Q1 net sales $1.3B (+1% YoY, +2.4% cc); net income $24.3M; adjusted diluted EPS $0.49; adjusted EBITDA $138.3M above guidance.
Herbalife closes $1.6B senior secured refinancing; issues $800M 12.25% notes due 2029
Issued $800M aggregate principal of 12.250% Senior Secured Notes due 2029 at 97.298% of par.
Herbalife prices upsized $800M senior secured notes at 12.25% due 2029
Offering upsized from $700M to $800M aggregate principal amount; priced at 97.298% of par.
Herbalife appoints Troy Hicks as COO, Frank Lamberti shifts to CCO effective May 31, 2024
Troy Hicks appointed Chief Operating Officer, effective May 31, 2024, succeeding Frank Lamberti.
Herbalife announces $700M senior secured notes offering due 2029 to refinance debt
HLF Financing SaRL, LLC and Herbalife International, Inc. to offer $700M senior secured notes due 2029.
Herbalife appoints John DeSimone as CFO; announces restructuring and 2024 guidance
John DeSimone appointed CFO effective March 17, 2024; Alex Amezquita remains with company.
Q4 net sales $1.2B, up 2.9% YoY (2.5% constant currency); net income $10.2M, diluted EPS $0.10.
Herbalife CEO Johnson signs new deal: $1.28M salary, $8M equity, term to Dec 2024
Base salary $1,280,000; annual bonus target $1,920,000 (max 300% of target).
Q3 net sales $1.3B, down 1.1% YoY (down 1.5% constant currency); third consecutive quarter of improved YoY trends.
Herbalife Q2 net sales $1.3B (-5.7% YoY); EPS $0.60; board member becomes CSO; targets Q4 growth
Q2 net sales $1.3B, down 5.7% YoY (4.2% constant currency); net income $59.9M.
Herbalife Q1 sales down 6.3% to $1.3B, EPS $0.29; COO Schissel retiring July 1
Net sales $1.3B, down 6.3% YoY (down 2.6% constant currency); reported net income $29.3M.
Herbalife Q4 net sales down 10.4%; Full year adj. EPS $3.40 vs $4.79; no FY2023 guidance
Full year 2022 net sales $5.2B, down 10.3% YoY; reported diluted EPS $3.23, adjusted $3.40 (down from $4.79).
Herbalife appoints Michael O. Johnson as permanent CEO with $1 salary, $10M equity grant
Johnson's term runs through Dec 31, 2023; annual base salary of $1; eligible for annual bonus of up to $2.4M payable in common shares.
Herbalife issues $250M 4.25% convertible senior notes due 2028
Issued $250M principal of 4.25% Convertible Senior Notes due June 15, 2028; net proceeds ~$243.5M.
Herbalife announces $250M convertible senior notes offering due 2028
Offering of $250M aggregate principal amount of convertible senior notes due 2028, plus option for initial purchasers to buy up to $37.5M additional.
Q3 2022 net sales of $1.3B, down 9.5% YoY (3.5% constant currency); reported diluted EPS $0.83, adjusted $0.91.
Herbalife Q2 beats guidance; President transitions to non-exec role; $400M digital plan
Q2 net sales $1.4B (-10.3% YoY, -5.9% FX-adjusted); adj. EPS $0.96 beat guidance; reported EPS $0.88.
Herbalife Q1 net sales $1.3B (-11% YoY); cuts FY2022 guidance; EPS $0.96 reported, $0.99 adjusted
Net sales $1.3B, down 11% YoY; two-year stack growth 5.8% vs Q1 2020.
FY2021 net sales $5.8B (+4.7% YoY); reported diluted EPS $4.13, adjusted $4.79 (records).
Herbalife Q3 net sales down 6% to $1.4B; adjusted EPS and EBITDA beat high-end guidance
Net sales of $1.4B, down 6% YoY; reported diluted EPS $1.09, adjusted diluted EPS $1.21, both up ~5% YoY.
Herbalife Nutrition cuts Q3/FY2021 guidance; net sales growth midpoint lowered 400 bps
Q3 net sales expected down 3.5%-6.5% vs 2020; prior midpoint lowered 700 bps.
Herbalife Q2 net sales $1.6B (+15% YoY); record adj. EBITDA $262M; raised EPS midpoint
Q2 net sales $1.6B (+15% YoY); reported EPS $1.31 vs $0.82; adjusted EPS $1.52 vs $0.97.
Herbalife Nutrition amends credit agreement, increases facilities and adds sustainability pricing
Increased Term Loan A facility from ~$245M to ~$286.2M and Revolving Credit facility from $282.5M to $330M.
Stephan Paulo Gratziani, the Company’s current President, was appointed as the Company’s Chief Executive Officer, effective May 1, 2025
Rob Levy, the Company’s current Managing Director, International, will succeed Mr. Gratziani to serve as the Company’s President – Worldwide Markets.
succeeding Michael O. Johnson, the Company’s current Chairman and Chief Executive Officer, who will concurrently transition to serve as the Company’s Executive Chairman.
On June 25, 2024, the Board of Directors (the “Board”) of Herbalife Ltd. (the “Company”) appointed Perkins Miller as a director to fill a newly created Board seat.
Troy Hicks was appointed as Chief Operating Officer of Herbalife Ltd. (the “Company”), succeeding Frank Lamberti
Frank Lamberti, the Company’s current Chief Operating Officer, who will concurrently move laterally to the role of Chief Commercial Officer, each effective May 31, 2024.
executed an employment agreement with John DeSimone in connection with his appointment as the Company’s Chief Financial Officer (the “CFO Employment Agreement”), effective March 17, 2024.
On March 17, 2024, Alex Amezquita ceased to serve as the Company’s Chief Financial Officer but will continue to serve as an employee of the Company.
On March 17, 2024, John DeSimone was appointed as the Company’s Chief Financial Officer.
On March 1, 2024, the Board of Directors (the “Board”) of Herbalife Ltd. (the “Company”) accepted the resignation of Board member Kevin M. Jones, which was previously delivered pursuant to the Company’s director resignation policy set forth in its Principles of Corporate Governance.
On March 1, 2024, the Board appointed Michael J. Levitt to fill the vacancy created by Mr. Jones’s departure.
On December 15, 2023, Mr. Stephan Paulo Gratziani was appointed as the President of Herbalife Ltd. (the “Company”), effective January 2, 2024.
Max materiality 0.85 · Median 0.70 · Most common event earnings